baber/WOPTO huggingface dataset:
Patent AU-2019261747-A1 (AU)
Title: Intraocular lens delivery systems and methods of use
Inventor: MATTHEWS GREGORY VINTON
IPC: A61F2/14
Filed: 2019-11-07
Abstract: An apparatus for deploying an intraocular lens comprises a delivery device having a lens receiving area, wherein the lens receiving area is configured to hold the intraocular lens in a deformed configuration. A plunger is disposed at a proximal end of the delivery device and a tapered portion at a distal end of the delivery device is configured to attach to a loading tube. The plunger is configured to be actuated in a distal direction to cause a fluid to flow in a distal direction to force the intraocular lens into the loading tube through the tapered portion.
Patent AU-2019264572-A1 (AU)
Title: System and method for suppressing vestibular activity of a human subject
Inventor: GALEA ANNA M
IPC: A61N1/36
Filed: 2019-11-13
Abstract: A system for suppressing vestibular activity of a human subject includes an electronics module configured to generate one or more electrical stimulation signals. A plurality of electrodes each placed proximate a predetermined location on a head of a human subject is configured to deliver the one or more electrical stimulation signals to the predetermined location to suppress vestibular activity of the human subject.
Patent AU-2019276906-A1 (AU)
Title: Prebiotic compositions and methods for maintaining a healthy skin microbiota
Inventor: DONEY ELIZABETH M
IPC: A61K8/33
Filed: 2019-05-22
Abstract: A composition for providing or maintaining a healthy skin microbiota and methods of providing or maintaining a healthy skin microbiota are disclosed. The composition can be a prebiotic composition that can include a carrier and a skin microbiota balancing agent. In some aspects, the skin microbiota balancing agent can include at least one combination of carbohydrate sources including a first carbohydrate source and a second carbohydrate source. The skin microbiota balancing agent can be configured to provide at least two of the following desired ratios: a first desired ratio of Corynebaderium to Staphylococcus of 1.3, a second desired ratio of Corynebaderium to Micrococcus of 1.4, and a third desired ratio of Staphylococcus to Micrococcus of 1.1. The carbohydrate sources may be D-alanine, D-threonine, L-alanyl-glycine, succinic acid, a-keto-glutaric acid, m-tantaric acid, bromo succinic acid, mucic acid, phenylethyl-amine, inulin, oxalic acid, pectin, Tween 40 etc.
Patent AU-2019295631-A1 (AU)
Title: Attached accelerator based inference service
Inventor: SENGUPTA SUDIPTA
IPC: G06F9/50
Filed: 2019-06-24
Abstract: Implementations detailed herein include description of a computer-implemented method. In an implementation, the method at least includes receiving an application instance configuration, an application of the application instance to utilize a portion of an attached accelerator during execution of a machine learning model and the application instance configuration including: an indication of the central processing unit (CPU) capability to be used, an arithmetic precision of the machine learning model to be used, an indication of the accelerator capability to be used, a storage location of the application, and an indication of an amount of random access memory to use.
Patent AU-2019305001-A1 (AU)
Title: Isoxazoline compounds for controlling invertebrate pests
Inventor: XU MING
IPC: A01N43/80
Filed: 2019-07-17
Abstract: Disclosed are Compounds of Formula (1) or (1'), wherein Q is (Q-1) or (Q-2); and R
Patent AU-2019309669-A1 (AU)
Title: Medical device support system having hub access opening
Inventor: BELLOWS LANCE CLARK
IPC: F16M11/20
Filed: 2019-07-22
Abstract: A medical device support system including a central shaft, an extension arm, and a brake assembly. The extension arm has a support for a medical device and a hub at its proximal end mounted to the central shaft for pivotable movement about the central shaft. The brake assembly is secured in the hub for rotation therewith and includes first and second discrete arc shape clamp pieces configured to flex toward and away from each other to respectively increase and decrease a frictional braking force to the central shaft. The hub includes a hub access opening configured to allow passage therethrough of at least one of the arc shape clamp pieces.
Patent AU-2019316523-A1 (AU)
Title: Two-stroke engine control
Inventor: LAWENIUS MATS
IPC: F02B63/02
Filed: 2019-06-27
Abstract: A two-stroke combustion engine comprising a user-operated throttle control, an adjustable valve arranged to control one or more air intakes of the combustion engine, and a control unit arranged to control a state of the adjustable valve, wherein the combustion engine is arranged to operate in a first idle mode at an idle engine speed below a clutch engagement engine speed when the user-operated throttle control is not engaged, wherein the combustion engine is arranged to operate in a second idle mode at a target engine speed above the clutch engagement engine speed when the user-operated throttle control is engaged and when the engine is not subject to an external load, the control unit being arranged to control the state of the adjustable valve to maintain engine speed at the target engine speed when the engine operates in the second idle mode.
Patent AU-2019321282-A1 (AU)
Title: Therapeutic protein selection in simulated in vivo conditions
Inventor: KIM DOROTHY
IPC: G01N33/543
Filed: 2019-08-12
Abstract: A method of determining the effect of non-specific interactions in simulated
Patent AU-2019326535-A1 (AU)
Title: Systems and methods for inspecting a microfluidic rotor device
Inventor: SHARTLE ROBERT JUSTICE
IPC: B29C65/14
Filed: 2019-08-22
Abstract: Described herein are various embodiments directed to rotor devices, systems, and kits. Embodiments of rotors disclosed herein may be used to characterize one or more analytes of a fluid. A method may include aligning an apparatus to an imaging device. The apparatus may include a set of wells defined by a first layer coupled to a second layer. The first layer may be substantially transparent to infrared radiation. The second layer may define a channel. The second layer may be substantially absorbent to the infrared radiation. The apparatus may further include a third layer coupled to the second layer and define an opening configured to receive a fluid. The third layer may be substantially transparent to the infrared radiation. A set of images of the apparatus may be generated using the imaging device. Bonding information may be generated based on the set of images.
Patent AU-2019346612-A1 (AU)
Title: Parallel tuned amplifiers
Inventor: YANKOWITZ JOSHUA AARON
IPC: H02J7/02
Filed: 2019-09-26
Abstract: The disclosed technology provides a system for transmitting wireless power for charging electronic devices, e.g., smartphones, medical appliances, industrial equipment, and robotics. Some embodiments include parallel tuned resonant LC networks, load networks, and impedance matching networks for Class D and E, single-ended or differential, amplifier topologies for wireless power transfer in resonant inductive systems.
Patent AU-2019370994-A1 (AU)
Title: Novel 6,7-dihydro-4H-pyrazolo(1,5-a)pyrazine indole-2-carboxamides active against the hepatitis B virus (HBV)
Inventor: DONALD ALASTAIR
IPC: A61K31/4985
Filed: 2019-11-01
Abstract: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for mating the compounds.
Patent AU-2019371154-A1 (AU)
Title: Computer-implemented communications by social media application
Inventor: FROLOVICHEV SERGEY
IPC: H04L12/58
Filed: 2019-10-30
Abstract: A computer implemented method includes supplying to a client device prompts for a first individual to specify matching criteria for a potential introduction to a second individual. The matching criteria includes a filter to sort a pool of individuals by a facial feature categorized by a facial recognition module. Matching criteria from the client device are collected. Matches between the first individual and a pool of individuals are generated based upon the matching criteria. The matches are supplied to the client device. A match acceptance by the first individual of the second individual is collected. Attributes of the second individual are verified to selectively establish a verified status. Network communication between the first individual and the second individual are enabled in response to the verified status.
Patent AU-2019382955-A1 (AU)
Title: Liver-specific regulatory nucleic acid sequences
Inventor: ROBERTS MICHAEL
IPC: C07K14/435
Filed: 2019-11-19
Abstract: The present invention relates to regulatory nucleic acid sequences, in particular liver-specific cis-regulatory elements, cis-regulatory modules, promoters and other such nucleic acid sequences, that are capable of enhancing liver-specific expression of genes. The invention also relates to expression constructs, vectors and cells comprising such liver-specific regulatory nucleic acid sequences, and to methods of their use. The liver-specific regulatory nucleic acid sequences are of particular utility for gene therapy applications, but also find utility in other areas such as bioprocessing and biotechnology.
Patent AU-2019383500-A1 (AU)
Title: New heterocyclic compounds
Inventor: KUHN BERND
IPC: A61K31/5365
Filed: 2019-11-20
Abstract: The invention provides new heterocyclic compounds having the general formula (I) wherein A, B, L, X, R
Patent AU-2019409693-A1 (AU)
Title: Ligand linker substrate
Inventor: KYHSE-ANDERSEN JAN
IPC: B01J20/30
Filed: 2019-12-17
Abstract: Ligand functionalized substrate including a solid substrate, which has been modified to provide grafted catching ligand groups covalently bound via a linker, methods of preparing said ligand functionalized substrate and the use thereof, such as to increase binding rate and the dynamic binding capacity (DBC).
Patent AU-2019474452-A1 (AU)
Title: Array substrate and display device
Inventor: HUANG YAO
IPC: H01L27/32
Filed: 2019-11-15
Abstract: An array substrate and a display device. The array substrate comprises: sub-pixels (11), which are located in a display region (B1) and comprise a light-emitting element, the light-emitting element comprising a first electrode, a light-emitting layer, and a second electrode; positive power source cables (12), which are located in the display region (B1) and are electrically connected to the first electrode; a positive power source bus (13), which is located in a peripheral region (B2) and is electrically connected to the positive power source cables (12); three positive power source access terminals (14, 15, 16), which are located on the side of the positive power source bus (13) away from the display region (B1) and are respectively electrically connected to the positive power source bus (13); a negative power source cable (17), which is located in the peripheral region (B2); an auxiliary electrode (18), which is located in the peripheral region (B2) and is electrically connected to the negative power source cable (17) and the second electrode, respectively; three negative power source access terminals (19, 20, 21), which are located on the side of the positive power source bus (13) away from the display region (B1) and are respectively electrically connected to the negative power source cable (17); and a negative power source auxiliary cable (22), which is located in the peripheral region (B2) and is electrically connected to the negative power source access terminal (20) and the auxiliary electrode (18), respectively. The present invention helps to ensure the uniformity of brightness of images displayed by the array substrate.
Patent AU-2019478689-A1 (AU)
Title: Helmet
Inventor: NAKASHIMA YOSHITO
IPC: A42B3/06
Filed: 2019-12-16
Abstract: Provided is a helmet that is removable from the head of a user (U) reliably and quickly by a third person. The helmet (1) according to the present invention has: a helmet body shell (3) for protecting the head of a user (U) and having an insertion opening (2) which is open downward; a shock absorption body (4) that is disposed on the inner circumferential side of the helmet body shell (3) and reduces shock to the head of the user (U); and a cushioning pad (5) that is disposed on the inner circumferential side of the shock absorption body (4) and fills the gap between the shock absorption body (4) and the head. The cushioning pad (5) has an emergency escape pad (12) at a position along an opening edge of the insertion opening (2). The emergency escape pad (12) has a pad bag (15) having an empty space inside, a pad body (14) housed in the pad bag (15), and a pad removal part (16) that allows the pad body (14) to be removed from the pad bag (15) in a state of being attached to the opening edge of the insertion opening (2).
Patent AU-2020200788-A1 (AU)
Title: Endotracheal tube insertion device
Inventor: GARDNER GLENN P
IPC: A61M25/01
Filed: 2020-02-04
Abstract: ENDOTRACHEAL TUBE INSERTION DEVICE An endotracheal tube insertion device (30) includes an insertion member (35), an optical assembly (36) movably mounted to the insertion member (35), and an intubation assembly (38). The intubation assembly (38) includes an intubation assembly body (72) and has a guide system formed thereon. The guide system is configured for releasable attachment to the optical assembly (36). An endotracheal tube (92) carried by the intubation assembly body (72).
Patent AU-2020203047-A1 (AU)
Title: Compositions and methods for antibodies targeting Factor P
Inventor: BRANNETTI BARBARA
IPC: C07K16/18
Filed: 2020-05-08
Abstract: I I\rec\nterwovn\NRPortbl\DCC\REC\10108592 I.docx-6/05/2016 The present invention relates to antibodies or antigen binding fragments thereof that bind to complement Factor P and used thereof as well as combinations of anti-Factor P antibodies with antibodies or antigen binding fragments thereof that bind to compelement component 5 (C5).
Patent AU-2020203165-A1 (AU)
Title: Methods of treating depression using NMDA modulators
Inventor: BURCH RON
IPC: C07D207/00
Filed: 2020-05-15
Abstract: METHODS OF TREATING DEPRESSION USING NMDA MODULATORS This disclosure provides methods and regimens for treating depression (e.g., treatment-resistant depression) in a patient (e.g., a patient in need of such treatment).
Patent AU-2020215330-A1 (AU)
Title: Wound dressing compositions and methods
Inventor: ELIYAHU-GROSS SHANI
IPC: A61F13/02
Filed: 2020-01-27
Abstract: Wound dressings comprising absorbable polyelectrolyte material and ionic crystals and methods of making the same are provided. The weight percent of ionic crystals in the polyelectrolyte materials can be adjusted for desired uses of the wound dressings.
Patent AU-2020216325-A1 (AU)
Title: Analyte sensors and sensing methods featuring dual detection of glucose and ketones
Inventor: FELDMAN BENJAMIN J
IPC: A61B5/145
Filed: 2020-01-28
Abstract: Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system comprising at least two enzymes that are capable of acting in concert to facilitate detection of ketones.
Patent AU-2020221681-A1 (AU)
Title: Production processes of S- and O-diacylated gamma-glutamyl-cysteamine prodrugs
Inventor: ANDERSON ROSALEEN JOY
IPC: C07C327/30
Filed: 2020-02-14
Abstract: Methods are provided for the synthesis of a compound of formula (X). R
Patent AU-2020225549-A1 (AU)
Title: Compositions comprising choline and omega-3 fatty acid to nutritionally enhance food products
Inventor: WOLFSON JONATHAN
IPC: A23L33/00
Filed: 2020-02-21
Abstract: Provided herein is a composition that includes choline or choline salt and omega-3 fatty acid for nutritionally enhancing a food product, as well as the resultant food products. The food product when nutritionally enhanced with the composition has an acceptable taste or acceptable odor or the food product has a peroxide value of less than 50 mEq. Methods of preparing the composition and food products are also are provided. As seen in the accompanying figure the discoveries outlined herein have resulted in an unprecedented level of organoleptic stability over time, with no significant change to key sensory parameters typically seen in products that contain high levels of choline and omega-3 fatty acids.
Patent AU-2020226893-A1 (AU)
Title: Multifunctional molecules that bind to T cell related cancer cells and uses thereof
Inventor: LOEW ANDREAS
IPC: C07K16/28
Filed: 2020-02-21
Abstract: Multifunctional molecules that include i) an antigen binding domain that binds to a T cell receptor beta chain constant domain 1 or T cell receptor beta chain constant domain 2; and one, two or all of: (ii) an immune cell engager (e.g., chosen from an NK cell engager, a T cell engager, a B cell engager, a dendritic cell engager, or a macrophage cell engager); (iii) a cytokine molecule or cytokine inhibitor molecule; (iv) a death receptor signal enhancer; and/or (v) a stromal modifying moiety are disclosed. Additionally disclosed are nucleic acids encoding the same, methods of producing the aforesaid molecules, and methods of treating a cancer using the aforesaid molecules.
Patent AU-2020230283-A1 (AU)
Title: Prevention of tissue ischemia, related methods and compositions
Inventor: ISENBERG JEFFREY S
IPC: G01N33/68
Filed: 2020-09-10
Abstract: Provided herein are compositions and methods for preventing, ameliorating, and/or 
reducing tissue ischemia and/or tissue damage due to ischemia, increasing blood 
vessel diameter, blood flow and tissue perfusion in the presence of vascular disease 
including peripheral vascular disease, atherosclerotic vascular disease, coronary 
artery disease, stroke and influencing other conditions, by suppressing CD47 and/or 
blocking TSP1 and/or CD47 activity or interaction. Influencing the interaction of 
CD47-TSP1 in blood vessels allows for control of blood vessel diameter and blood 
flow, and permits modification of blood pressure and cardiac function. Under 
conditions of decreased blood flow, for instance through injury or atherosclerosis, 
blocking TSP1-CD47 interaction allows blood vessels to dilate and increases blood 
flow, tissue perfusion and tissue survival. This in turn reduces or prevents tissue 
necrosis and death. The therapeutics identified herein allow for precise regulation of 
blood flow to tissues and organs which need it, while substantially avoiding systemic 
complications. Methods and compositions described herein can be used to increase 
tissue survival under conditions of trauma and surgery, as well as conditions of 
chronic vascular disease. Also disclosed are methods for the treatment of elderly 
subjects using agents that affect TSP1 and CD47 and thereby affect tissue 
perfusion. Additionally, provided herein are compositions and methods for 
influencing blood coagulation, allowing for controlled increased or decreased blood 
clotting. Additionally, provided herein are compositions and methods for decreasing 
blood flow, as in the case of cancer through mimicking the effects of TSP1 and CD47 
on blood vessel diameter and blood flow.
Patent AU-2020234718-A1 (AU)
Title: Compositions and methods for promoting islet viability and enhancing insulin secretion
Inventor: LAURIE GORDON W
IPC: A61K35/39
Filed: 2020-03-13
Abstract: Compositions and methods for regenerating pancreatic islet viability and/or cell proliferation in vitro, ex vivo, and/or in vivo; and/or for regenerating glucose-stimulated insulin secretion; and/or for regenerating viability and/or cell proliferation of a transplanted pancreatic islets; and/or for preventing and/or inhibiting rejection of a transplanted islets; and/or for pancreatic islet transplantation; and/or for treating a symptom of a condition, disorder, or disease associated with abnormal insulin responsiveness to glucose are provided. In some embodiments, the compositions include a peptide and/or a pharmaceutically acceptable salt thereof, and/or a biologically active fragment, analog, or derivative thereof, wherein the peptide, the pharmaceutically acceptable salt thereof, and/or the biologically active fragment, analog, or derivative thereof has an amino acid sequence of any of SEQ ID NOs: 1-60, or any combination thereof.
Patent AU-2020244413-A1 (AU)
Title: Coffee machine
Inventor: CINGOLANI CLAUDIO ENRICO
IPC: A47J31/00
Filed: 2020-09-29
Abstract: COFFEE MACHINE 
Coffee machine (10) comprising a main body comprising: 
5 a circuit for dispensing coffee having an inlet for 
that can be hydraulically connected to a water supply 
line; a central processing and control unit (20) 
configured to control at least said circuit for 
dispensing coffee; a communication interface (22) 
10 configured to connect with a telecommunications network 
(50); a sensor system for the detection of parameters 
related to possible operation anomalies or failures of 
said coffee machine (10) provided inside said main 
body; a peripheral processing unit (40) at least 
15 connected to the sensor system and configured to carry 
out a first local processing of the data detected by 
the sensors (12, 13) and to send the locally processed 
data to one or more remote server (30) by the 
communication interface (22).  
20
Patent AU-2020255671-A1 (AU)
Title: Biological sample capturing device
Inventor: DARLINGTON BRONWYN
IPC: A61B5/097
Filed: 2020-03-31
Abstract: In one embodiment, the present invention provides a biological sample capture device comprising a body including a chamber, the chamber being arranged to sealingly hold a biological sample, a first valve in communication with the chamber, wherein the first valve allows a biological sample to enter the chamber, a second valve in communication with the chamber, wherein the second valve is arranged to expel air from the chamber upon a biological sample entering the chamber via the first valve.
Patent AU-2020261313-A1 (AU)
Title: Intersecting nozzles arrangement
Inventor: EDWARDS MICHAEL
IPC: B05B1/00
Filed: 2020-04-29
Abstract: A nozzle assembly (2) comprising a plurality of conduit means for delivering respective fluid substances from respective fluid containers to a plurality of corresponding outlet nozzles (6), wherein the plurality of outlet nozzles (6) are arranged about a central axis (8) of said assembly and to emit their respective fluids as converging streams to converge at a blending zone externally of the nozzle assembly (2).
Patent AU-2020273597-A1 (AU)
Title: Immunogenic peptides with an oxidoreductase motif comprising a modified cysteine
Inventor: ERAK MILOS
IPC: A61K39/00
Filed: 2020-05-18
Abstract: The invention relates to immunogenic peptides comprising T-cell epitopes and oxidoreductase motifs comprising a modified cysteine, and their use in regulating the immune response in subjects.